Smith+Nephew announced today that it aims to develop technology in a new field of arthroscopic surgical innovation.

Smith & Nephew (NYSE:SNN) quickly edged higher by ~1% after a report that it's considering a break-up amid activist pressure.

Healthcare professionals are invited to register for the livestream option as a courtesy here Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the inaugural ...

It is critical to understand the sex-related differences influencing ACL injuries to improve research and care ... Competing interests AMJG has received royalties from Smith & Nephew and Graymont Inc.

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the launch of a comprehensive foot & ankle repair portfolio in Australia and New Zealand (ANZ) with ...